Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 17/20 | 0.61 |
| ▸ | CCNE1 | P24864 | 11/20 | 0.61 |
| ▸ | CDK1 | P06493 | 9/20 | 0.61 |
| ▸ | CDK9 | P50750 | 7/20 | 0.59 |
| ▸ | CCNT1 | O60563 | 5/20 | 0.59 |
| ▸ | CCNE2 | O96020 | 2/20 | 0.59 |
| ▸ | CCNT2 | O60583 | 1/20 | 0.59 |
| ▸ | CDK5 | Q00535 | 6/20 | 0.49 |
| ▸ | CACNA1B | Q00975 | 5/20 | 0.49 |
| ▸ | CDK5R1 | Q15078 | 4/20 | 0.49 |
| ▸ | CCNB1 | P14635 | 4/20 | 0.49 |
| ▸ | CCNB2 | O95067 | 3/20 | 0.49 |
| ▸ | CCNB3 | Q8WWL7 | 3/20 | 0.49 |
| ▸ | CCNA2 | P20248 | 6/20 | 0.48 |
| ▸ | CCNA1 | P78396 | 6/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | CDK7 | P50613 | 4/20 | 0.47 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.47 |
| ▸ | CLK2 | P49760 | 2/20 | 0.47 |
| ▸ | CSNK1G2 | P78368 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1354380 | 0.94 | CDK2 (0.61) | CDK2CCNE1CDK1CDK9CCNT1 | |
| SCHEMBL1355670 | 0.91 | CDK2 (0.60) | CDK2CCNE1CDK1CDK9CCNT1 | |
| SCHEMBL1353916 | 0.91 | CDK2 (0.60) | CDK2CCNE1CDK1CDK9CCNT1 | |
| SCHEMBL1352488 | 0.91 | CDK2 (0.60) | CDK2CCNE1CDK1CDK9CCNT1 | |
| SCHEMBL15118297 | 0.91 | CDK2 (0.71) | CDK2CCNE1CDK1CDK9CCNT1 | |
| SCHEMBL1355787 | 0.90 | CDK2 (0.58) | CDK2CCNE1CDK1CDK9CCNT1 | |
| SCHEMBL1353804 | 0.90 | CDK2 (0.68) | CDK2CCNE1CDK1CDK9CCNT1 | |
| SCHEMBL1355223 | 0.89 | CDK1 (0.51) | CDK2CCNE1CDK1CDK9CCNT1 | |
| SCHEMBL1354548 | 0.88 | CDK2 (0.51) | CDK2CCNE1CDK1CDK9CCNT1 | |
| SCHEMBL1352962 | 0.88 | CCNE1 (0.50) | CDK2CCNE1CDK1CDK9CCNT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9023857-B2 | Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2015-05-05 | — | — | US | disclosed |
| EP-2391626-B1 | SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS | Univerzita Palackého v Olomouci (CZ) | 2014-10-01 | — | — | EP | disclosed |
| US-20110287111-A1 | SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS | UNIVERZITA PALACKEHO V OLOMOUCI (CZ) | 2011-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110287111-A1 | SUBSTITUTED 6-(2-AMINOBENZYLAMINO)PURINE DERIVATIVES, THEIR USE AS MEDICAMENTS AND PREPARATIONS CONTAINING THESE COMPOUNDS | CDK6, CCNI, CDK2 | CDK2 3/4885CCNE1 55/4885CDK1 4/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.